http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1554284-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5305109c4efec4cbcdd8bc05bdb00399
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D515-02
filingDate 2003-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb392646c0eed2aa0f2961536dc5140b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af4a21e09215cda7e440429cdb62ca4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec7b6a3173d17ba4307b6f35c583298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5c0d0778472a6511b232b8e656a7e67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67ba19c3ee4da971b4ecfe53d9915ae4
publicationDate 2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1554284-A1
titleOfInvention Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate
abstract A method for manufacturing hydrogen sulphate (alpha S) of the alpha-(2-chlorophenyl)-6,7­dihydro-thieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester (clopidogrel hydrogen sulphate) of formula I, in crystalline Form I, wherein the compound of formula is separated out of a solution of clopidogrel in the form of the free base or salt in a solvent selected from the series of primary, secondary or tertiary C1-C5 alcohols, their esters with Cl-C4 carboxylic acids, or optionally of mixtures thereof.
priorityDate 2002-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035652-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03051362-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9861403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227282241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127712924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11647133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57462735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228066398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405493

Total number of triples: 48.